STAT3 and neoplasm: The nanoRNP conjugated with single guide RNAs (sgRNAs) specifically targeted and disrupted STAT3 and RUNX1 expression, thereby inhibiting the heterogenous tumor populations in glioblastoma U87MG cells and in a xenograft model [210].